Serum levels of ET-1, M30, and angiopoietins-1 and -2 in HELLP syndrome and preeclampsia compared to controls

Archives of Gynecology and Obstetrics

Volumn 293, Issue 2, 2016, Pages 351-359

  Karakus, Savas ^a   Bozoklu Akkar, Ozlem ^a   Yildiz, Caglar ^a   Sancakdar, Enver ^a   Cetin, Meral ^a   Cetin, Ali ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

Author keywords

Angiopoietin 1; Angiopoietin 2; Endothelin 1; HELLP syndrome; M30; Preeclampsia

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; CASPASE CLEAVED CYTOKERATIN 18 FRAGMENT; CYTOKERATIN 18; ENDOTHELIN 1; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; M30 CYTOKERATIN-18 PEPTIDE, HUMAN; PEPTIDE FRAGMENT;

ADULT; AGE; ARTICLE; BODY MASS; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HELLP SYNDROME; HUMAN; MAJOR CLINICAL STUDY; PARITY; PREECLAMPSIA; PREGNANCY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; THROMBOCYTE COUNT; BLOOD; CASE CONTROL STUDY; CHEMISTRY; FETUS BLOOD; PRE-ECLAMPSIA; PREGNANT WOMAN;

ADULT; ANGIOPOIETIN-1; ANGIOPOIETIN-2; BIOMARKERS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ENDOTHELIN-1; FEMALE; FETAL BLOOD; GRAVIDITY; HELLP SYNDROME; HUMANS; KERATIN-18; PARITY; PEPTIDE FRAGMENTS; PRE-ECLAMPSIA; PREGNANCY; PREGNANT WOMEN;

EID: 84954400634     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-015-3803-1     Document Type: Article

References (52)

1. Prusac IK, Zekic Tomas S, Roje D (2011) Apoptosis, proliferation and Fas ligand expression in placental trophoblast from pregnancies complicated by HELLP syndrome or pre-eclampsia. Acta Obstet Gynecol Scand 90(10):1157–1163
2. Haram K, Svendsen E, Abildgaard U (2009) The HELLP syndrome: clinical issues and management. A Review. BMC Pregnancy Childbirth 26(9):8
3. Jebbink J, Wolters A, Fernando F, Afink G, van der Post J (1822) Ris-Stalpers C (2012) Molecular genetics of preeclampsia and HELLP syndrome—a review. Biochim Biophys Acta 12:1960–1969
4. John K, Wielgosz S, Schulze-Osthoff K, Bantel H, Hass R (2013) Increased plasma levels of CK-18 as potential cell death biomarker in patients with HELLP syndrome. Cell Death Dis 24(4):e886
5. Shinagawa T, Suzuki S, Sawa R, Yoneyama Y, Asakura H, Araki T (2002) Maternal plasma adenosine and endothelin-1 levels in twin gestation complicated by preeclampsia. Arch Gynecol Obstet 267(2):72–75
6. Nezar MA, el-Baky AM, Soliman OA, Abdel-Hady HA, Hammad AM, Al-Haggar MS (2009) Endothelin-1 and leptin as markers of intrauterine growth restriction. Indian J Pediatr 76(5):485–488
7. Zhang LJ, Han YH, Han YZ (2010) Serum soluble Endoglin, plasma endothelin-1 and coagulation function in early onset severe preeclampsia with organ dysfunction. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 22(6):371–374
8. Celik H, Avci B, Işik Y (2013) Vascular endothelial growth factor and endothelin-1 levels in normal pregnant women and pregnant women with pre-eclampsia. J Obstet Gynaecol 33(4):355–358
9. Bantel H, Ruck P, Gregor M, Schulze-Osthoff K (2001) Detection of elevated caspase activation and early apoptosis in liver diseases. Eur J Cell Biol 80(3):230–239
10. Hefler LA, Tempfer CB, Bancher-Todesca D, Schatten C, Husslein P, Heinze G, Gregg AR (2001) Placental expression and serum levels of cytokeratin-18 are increased in women with preeclampsia. J Soc Gynecol Investig 8(3):169–173
11. Bantel H, Lügering A, Heidemann J, Volkmann X, Poremba C, Strassburg CP, Manns MP, Schulze-Osthoff K (2004) Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury. Hepatology 40(5):1078–1087
12. Hamad RR, Bremme K, Kallner A, Sten-Linder M (2009) Increased levels of an apoptotic product in the sera from women with pre-eclampsia. Scand J Clin Lab Invest 69(2):204–208
13. Seidel N, Volkmann X, Länger F, Flemming P, Manns MP, Schulze-Osthoff K, Bantel H (2005) The extent of liver steatosis in chronic hepatitis C virus infection is mirrored by caspase activity in serum. Hepatology 42(1):113–120
14. Joka D, Wahl K, Moeller S, Schlue J, Vaske B, Bahr MJ, Manns MP, Schulze-Osthoff K, Bantel H (2012) Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis. Hepatology 55(2):455–464
15. MacFarlane M, Merrison W, Dinsdale D, Cohen GM (2000) Active caspases and cleaved cytokeratins are sequestered into cytoplasmic inclusions in TRAIL-induced apoptosis. J Cell Biol 148(6):1239–1254
16. Chittiboina P, Ganta V, Monceaux CP, Scott LK, Nanda A, Alexander JS (2013) Angiopoietins as promising biomarkers and potential therapeutic targets in brain injury. Pathophysiology 20(1):15–21
17. Thurston G, Daly C (2012) The complex role of angiopoietin-2 in the angiopoietin-tie signaling pathway. Cold Spring Harb Perspect Med 2(9):a006550
18. Eklund L, Saharinen P (2013) Angiopoietin signaling in the vasculature. Exp Cell Res 319(9):1271–1280
19. Page AV, Liles WC (2013) Biomarkers of endothelial activation/dysfunction in infectious diseases. Virulence 4(6):507–516
20. Bolin M, Wiberg-Itzel E, Wikström AK, Goop M, Larsson A, Olovsson M, Akerud H (2009) Angiopoietin-1/angiopoietin-2 ratio for prediction of preeclampsia. Am J Hypertens 22(8):891–895
21. Shim SS, Lee CH, Jun JK (2015) Midtrimester maternal plasma concentrations of angiopoietin 1, angiopoietin 2, and placental growth factor in pregnant women who subsequently develop preeclampsia. Obstet Gynecol Sci. 58(1):10–16
22. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM (2001) The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 20(1):IX–XIV
23. Sibai BM, Taslimi MM, el-Nazer A, Amon E, Mabie BC, Ryan GM (1986) Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 155(3):501–509
24. Abildgaard U, Heimdal K (2013) Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review. Eur J Obstet Gynecol Reprod Biol 166(2):117–123
25. Benedetto C, Marozio L, Tancredi A, Picardo E, Nardolillo P, Tavella AM, Salton L (2011) Biochemistry of HELLP syndrome. Adv Clin Chem 53:85–104
26. Kalinderis M, Papanikolaou A, Kalinderi K, Vyzantiadis TA, Ioakimidou A, Tarlatzis BC (2015) Serum levels of leptin and IP-10 in preeclampsia compared to controls. Arch Gynecol Obstet 292(2):343–347
27. Kuc S, Koster MP, Franx A, Schielen PC, Visser GH (2013) Maternal characteristics, mean arterial pressure and serum markers in early prediction of preeclampsia. PLoS One 8(5):e63546
28. Artunc-Ulkumen B, Guvenc Y, Goker A, Gozukara C (2015) Maternal Serum S100-B, PAPP-A and IL-6 levels in severe preeclampsia. Arch Gynecol Obstet 292(1):97–102
29. Simetka O, Klat J, Gumulec J, Dolezalkova E, Salounova D, Kacerovsky M (2015) Early identification of women with HELLP syndrome who need plasma exchange after delivery. Transfus Apher Sci 52(1):54–59
30. Paradis A, Zhang L (2013) Role of endothelin in uteroplacental circulation and fetal vascular function. Curr Vasc Pharmacol 11(5):594–605
31. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T (1989) The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A 86(8):2863–2867
32. Gao Y, Raj JU (2010) Regulation of the pulmonary circulation in the fetus and newborn. Physiol Rev 90(4):1291–1335
33. Agapitov AV, Haynes WG (2002) Role of endothelin in cardiovascular disease. J Renin Angiotensin Aldosterone Syst 3(1):1–15
34. Bussen S, Sütterlin M, Steck T (1999) Plasma endothelin and big endothelin levels in women with severe preeclampsia or HELLP-syndrome. Arch Gynecol Obstet 62(3–4):113–119
35. Taylor RN, Varma M, Teng NN, Roberts JM (1990) Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrinol Metab 71(6):1675–1677
36. Baksu B, Davas I, Baksu A, Akyol A, Gulbaba G (2005) Plasma nitric oxide, endothelin-1 and urinary nitric oxide and cyclic guanosine monophosphate levels in hypertensive pregnant women. Int J Gynaecol Obstet 90(2):112–117
37. Nishikawa S, Miyamoto A, Yamamoto H, Ohshika H, Kudo R (2000) The relationship between serum nitrate and endothelin-1 concentrations in preeclampsia. Life Sci 67(12):1447–1454
38. Maltaris T, Scalera F, Schlembach D, Hoffmann I, Mueller A, Binder H, Goecke T, Hothorn T, Schild RL, Beckmann MW, Dittrich R (2005) Increased uterine arterial pressure and contractility of perfused swine uterus after treatment with serum from pre-eclamptic women and endothelin-1. Clin Sci (Lond) 109(2):209–215
39. Omary MB, Ku NO, Toivola DM (2002) Keratins: guardians of the liver. Hepatology 35(2):251–257
40. Bae CB, Kim SS, Ahn SJ, Cho HJ, Kim SR, Park SY, Song GW, Kim DJ, Hwang SG, Yang JM, Kim YB, Park YN, Shin SJ, Cho SW, Cheong JY (2013) Caspase-cleaved fragments of cytokeratin-18 as a marker of inflammatory activity in chronic hepatitis B virus infection. J Clin Virol 58(4):641–646
41. Thurston G (2003) Role of Angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis. Cell Tissue Res 314(1):61–68
42. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277(5322):55–60
43. Kim I, Kim JH, Ryu YS, Liu M, Koh GY (2000) Tumor necrosis factor-alpha upregulates angiopoietin-2 in human umbilical vein endothelial cells. Biochem Biophys Res Commun 269(2):361–365
44. Augustin HG, Koh GY, Thurston G, Alitalo K (2009) Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 10(3):165–177
45. Witzenbichler B, Maisonpierre PC, Jones P, Yancopoulos GD, Isner JM (1998) Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie 2. J Biol Chem 273(29):18514–18521
46. Scholz A, Rehm VA, Rieke S, Derkow K, Schulz P, Neumann K, Koch I, Pascu M, Wiedenmann B, Berg T, Schott E (2007) Angiopoietin-2 serum levels are elevated in patients with liver cirrhosis and hepatocellular carcinoma. Am J Gastroenterol 102(11):2471–2481
47. Llovet JM, Peña CE, Lathia CD, Shan M, Meinhardt G, Bruix J (2012) SHARP Investigators Study Group. Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma. Clin Cancer Res 18(8):2290–2300
48. Aref S, Goda H, Abdelaal E (2013) Circulating vascular growth factor (VEGF) Angiopoietin-1 (Angi-1) and soluble Tie-2 receptor in pregnancy complicated with pre-eclampsia: a prospective study. J Obstet Gynaecol India 63(5):316–320
49. Han SY, Jun JK, Lee CH, Park JS, Syn HC (2012) Angiopoietin-2: a promising indicator for the occurrence of severe preeclampsia. Hypertens Pregnancy 31(1):189–199
50. Khalil A, Maiz N, Garcia-Mandujano R, Elkhouli M, Nicolaides KH (2014) Longitudinal changes in maternal soluble endoglin and angiopoietin-2 in women at risk for pre-eclampsia. Ultrasound Obstet Gynecol 44(4):402–410
51. Kappou D, Sifakis S, Androutsopoulos V, Konstantinidou A, Spandidos DA, Papantoniou N (2014) Placental mRNA expression of angiopoietins (Ang)-1, Ang-2 and their receptor Tie-2 is altered in pregnancies complicated by preeclampsia. Placenta 35(9):718–723
52. Kamal M, El-Khayat W (2011) Do serum angiopoietin-1, angiopoietin-2, and their receptor Tie-2 and 4G/5G variant of PAI-1 gene have a role in the pathogenesis of preeclampsia? J Investig Med 59(7):1147–1150